Panel: Accelerating Drug Discovery in Stem Cell Models

Are we getting closer to clinical trials in a dish? This interactive panel discussion featuring academic and industry leaders highlights how stem cell models of disease are combining with new technologies such as artificial intelligence to identify new drugs more effectively. Daniel Paull, PhD — The NYSCF Research Institute 00:00 Leveraging automation and AI to streamline and scale iPSC-based drug screening 14:22 Panel (L–R) Moderator: Christine Brideau – Deerfield Management Daniel Paull, PhD — The NYSCF Research Institute Tim Ahfeldt, PhD — Recursion Pharmaceuticals Beth Cimini, PhD — Broad Institute Daniel Ramos, PhD — National Institute on Aging Presented at: The 2023 NYSCF Conference #drugdiscovery #ptsd #alzheimers #multiplesclerosis #parkinsons #rarediseases #stemcell